Analgesics - Qatar

  • Qatar
  • In Qatar, the revenue generated in the Analgesics market in 2024 amounts to US$88.29m.
  • It is projected that the market will experience an annual growth rate of 6.66% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in the Analgesics market, reaching US$7,243.00m in 2024.
  • In terms of per person revenues, in Qatar generates US$32.26 in 2024.
  • Qatar's analgesics market is experiencing a surge in demand due to the growing population and increasing prevalence of chronic pain conditions.

Key regions: Brazil, Europe, Germany, Canada, United States

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Qatar is experiencing steady growth due to several key factors. Customer preferences for pain relief medication, along with trends in the market, and local special circumstances all contribute to the development of the market. Additionally, underlying macroeconomic factors play a role in shaping the growth of the Analgesics market in Qatar.Customer preferences in Qatar for pain relief medication tend to favor over-the-counter (OTC) options. This preference is driven by convenience and accessibility, as consumers can easily purchase these medications without a prescription. Additionally, customers in Qatar often prioritize quick relief from pain, which makes OTC analgesics a popular choice. This preference for OTC analgesics aligns with global trends, as consumers worldwide are increasingly seeking self-care options for managing pain.Trends in the Analgesics market in Qatar reflect the growing demand for natural and herbal pain relief options. Consumers are becoming more health-conscious and are seeking products that are perceived as safer and more natural. As a result, there is a rising demand for analgesics made from natural ingredients, such as herbal extracts. This trend is also influenced by global consumer preferences, as natural and herbal remedies gain popularity worldwide.Local special circumstances in Qatar, such as the high prevalence of chronic conditions and an aging population, contribute to the development of the Analgesics market. Chronic conditions, such as arthritis and back pain, are common among the population, leading to a sustained demand for pain relief medication. Additionally, the aging population in Qatar requires increased access to analgesics for managing age-related pain and discomfort. These local factors create a favorable market environment for the growth of the Analgesics market in Qatar.Underlying macroeconomic factors, such as the overall economic growth and healthcare expenditure, also play a role in the development of the Analgesics market in Qatar. As the economy grows, consumers have more disposable income to spend on healthcare products, including analgesics. Furthermore, increased healthcare expenditure by the government and private sector contributes to the accessibility and availability of analgesics in the market. These macroeconomic factors create a conducive environment for the growth of the Analgesics market in Qatar.In conclusion, the Analgesics market in Qatar is developing due to customer preferences for OTC options, trends in the market favoring natural and herbal remedies, local special circumstances such as the prevalence of chronic conditions and an aging population, and underlying macroeconomic factors such as economic growth and healthcare expenditure. These factors collectively contribute to the steady growth of the Analgesics market in Qatar.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)